Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Calcified Tissue International|January 1, 1995
Bone-resorbing activities of 24-epi-1 alpha-hydroxyvitamin D2 and 24-epi-1 alpha,25-dihydroxyvitamin D2K Yokoyama, T Miyahara, M Matsumoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1987
[Lymphocyte cytotoxicity against autologous tumor cells and the effect of interferon-beta on their activities. (2) Evaluation of large granular lymphocytes (LGL)]K Ezaki, N Ito, M Suzuki, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 13, 2009
Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in JapanT Hibi, Y Sameshima, Y Sekiguchi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1994
[Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin]M Okamoto, F Maruyama, M Tsuzuki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 10, 2000
[Retrospective study of acute myelogenous leukemia in elderly patients: treatment and outcome of 83 consecutive patients]T Ino, M Tsuzuki, A Hasegawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[High-dose adjuvant chemotherapy with peripheral blood stem cell transplantation for breast cancer with poor prognosis--a pilot study]F Maruyama, K Ezaki, H Miyazaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1993
[A study of toxicities and complications observed in alternating non-cross-resistant chemotherapy (CAMBO-VIP) for non-Hodgkin's lymphoma]F Maruyama, K Ezaki, M Okamoto, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1993
[Rearrangements of immunoglobulin light chain and heavy chain constant region genes in B-cell malignancies]F Maruyama, T Ino, H Miyazaki, et al.Leukemia Research|January 1, 1995
Interleukin-1 beta (IL-1 beta) and acute leukemia: in vitro proliferative response to IL-1 beta, IL-1 beta content of leukemic cells and treatment outcomeK Ezaki, M Tsuzuki, I Katsuta, et al.Leukemia Research|June 1, 1992
Intensive sequential post-induction therapy for adults with acute myelogenous leukemia in first remission: long-term follow-up and resultsT Ino, H Kojima, H Miyazaki, et al.Pageof 5